approval
saveTUZISTRA XR (CHLORPHENIRAMINE POLISTIREX) — FDA approval
community read0 votes
Sponsor: TRIS PHARMA INC. Form: SUSPENSION, EXTENDED RELEASE. Route: ORAL
view source ↗Data sources
last refreshed 5mo ago
Found something off?
drug timeline · 8
- approvalTUZISTRA XR (CHLORPHENIRAMINE POLISTIREX) — FDA approvalDec 22, 2025 · 282d ago
- approvalTUZISTRA XR (CHLORPHENIRAMINE POLISTIREX) — FDA approvalJun 28, 2018 · 3016d ago
- approvalTUZISTRA XR (CHLORPHENIRAMINE POLISTIREX) — FDA approvalAug 29, 2017 · 3319d ago
- approvalTUZISTRA XR (CHLORPHENIRAMINE POLISTIREX) — FDA approvalFeb 17, 2017 · 3512d ago
- approvalTUZISTRA XR (CHLORPHENIRAMINE POLISTIREX) — FDA approvalJan 13, 2017 · 3547d ago
- approvalTUZISTRA XR (CHLORPHENIRAMINE POLISTIREX) — FDA approvalFeb 19, 2016 · 3876d ago
- approvalTUZISTRA XR (CHLORPHENIRAMINE POLISTIREX) — FDA approvalDec 4, 2015 · 3953d ago
- approvalTUZISTRA XR (CHLORPHENIRAMINE POLISTIREX) — FDA approvalApr 30, 2015 · 4171d ago
same company · ±60 days · 3
- approvalacetaminophen ER: HYDROCODONE BITARTRATE AND ACETAMINOPHEN (ACETAMINOPHEN) — FDA approvalDec 15, 2023
- approvalacetaminophen ER: HYDROCODONE BITARTRATE AND ACETAMINOPHEN (ACETAMINOPHEN) — FDA approvalDec 15, 2023
- approvalacetaminophen ER: HYDROCODONE BITARTRATE AND ACETAMINOPHEN (ACETAMINOPHEN) — FDA approvalDec 15, 2023
comments(0)
5-min edit window · permanent after that